Mantravadi et al. [57] recently conducted a large retrospective cohort study in patients with PsA, RA, or ankylosing spondylitis (AS) who had comorbid diabetes and newly initiated either a TNF inhibitor, MTX, or metformin (patients who received metformin served as positive controls). The gene discussed is TNF; the disease is rheumatoid arthritis.